MICHELLE SABLATURA: Open Payments
NPI 1760153514 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 29 payments from 17 companies in 2025. Trend: 2023 $288 · 2024 $1,013 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| ABBVIE INC. | 4 | $87 |
| Novo Nordisk Inc | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $38 |
| Abbott Laboratories | 1 | $26 |
| Viatris Specialty LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Corcept Therapeutics | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: Kerendia, VRAYLAR, Ozempic, JARDIANCE, Cologuard Collection Kit, FREESTYLE LIBRE 3, YUPELRI, Veozah.
Industry payments across TX — which companies pay providers there.
